These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


243 related items for PubMed ID: 12127638

  • 41. Overview of the relationship between use of progestogen-only contraceptives and bone mineral density.
    Banks E, Berrington A, Casabonne D.
    BJOG; 2001 Dec; 108(12):1214-21. PubMed ID: 11843382
    [Abstract] [Full Text] [Related]

  • 42. The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age.
    Gai L, Zhang J, Zhang H, Gai P, Zhou L, Liu Y.
    Contraception; 2011 Mar; 83(3):218-22. PubMed ID: 21310282
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK.
    Kyvernitakis I, Kostev K, Nassour T, Thomasius F, Hadji P.
    Osteoporos Int; 2017 Jan; 28(1):291-297. PubMed ID: 27461017
    [Abstract] [Full Text] [Related]

  • 48. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M.
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Steroidal contraceptives: effect on bone fractures in women.
    Lopez LM, Grimes DA, Schulz KF, Curtis KM, Chen M.
    Cochrane Database Syst Rev; 2014 Jun 24; 2014(6):CD006033. PubMed ID: 24960023
    [Abstract] [Full Text] [Related]

  • 51. Bone mineral density in adolescent females using depot medroxyprogesterone acetate.
    Lara-Torre E, Edwards CP, Perlman S, Hertweck SP.
    J Pediatr Adolesc Gynecol; 2004 Feb 24; 17(1):17-21. PubMed ID: 15010034
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women.
    Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM.
    Contraception; 2004 Feb 24; 69(2):99-104. PubMed ID: 14759613
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Bone density recovery after depot medroxyprogesterone acetate injectable contraception use.
    Kaunitz AM, Arias R, McClung M.
    Contraception; 2008 Feb 24; 77(2):67-76. PubMed ID: 18226668
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.